Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice

Tomohiro Tanaka, Hiroaki Masuzaki, Ken Ebihara, Yoshihiro Ogawa, Shintaro Yasue, Hideo Yukioka, Hideki Chusho, Fumiko Miyanaga, Takashi Miyazawa, Muneya Fujimoto, Toru Kusakabe, Nozomi Kobayashi, Tatsuya Hayashi, Kiminori Hosoda, Kazuwa Nakao

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Steatosis is one of the most common liver diseases and is associated with the metabolic syndrome. A line of evidence suggests that peroxisome proliferator-activated receptor (PPAR) α and PPARγ are involved in its pathogenesis. Hepatic overexpression of PPARγ1 in mice provokes steatosis, whereas liver-specific PPARγ disruption ameliorates steatosis in ob/ob mice, suggesting that hepatic PPARγ functions as an aggravator of steatosis. In contrast, PPARα-null mice are susceptible to steatosis because of reduced hepatic fatty acid oxidation. PPARγ with mutations in its C-terminal ligand-binding domain (L468A/E471A mutant PPARγ1) have been reported as a constitutive repressor of both PPARα and PPARγ activities in vitro. To elucidate the effect of cosuppression of PPARα and PPARγ on steatosis, we generated mutant PPARγ transgenic mice (Liver mt PPARγ Tg) under the control of liver-specific human serum amyloid P component promoter. In the liver of transgenic mice, PPARα and PPARγ agonist-induced augmentation of the expression of downstream target genes of PPARα and PPARγ, respectively, was significantly attenuated, suggesting PPARα and PPARγ cosuppression in vivo. Suppression of PPARα and PPARγ target genes was also observed in the fasted and high-fat-fed conditions. Liver mt PPARγ Tg were susceptible to fasting-induced steatosis while being protected against high-fat diet-induced steatosis. The opposite hepatic outcomes in Liver mt PPARγ Tg as a result of fasting and high-fat feeding may indicate distinct roles of PPARα and PPARγ in 2 different types of nutritionally provoked steatosis.

Original languageEnglish
Pages (from-to)1490-1498
Number of pages9
JournalMetabolism: Clinical and Experimental
Volume54
Issue number11
DOIs
Publication statusPublished - Nov 1 2005

Fingerprint

Peroxisome Proliferator-Activated Receptors
High Fat Diet
Fasting
Liver
RNA Interference
Transgenic Mice
Fats
Serum Amyloid P-Component

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. / Tanaka, Tomohiro; Masuzaki, Hiroaki; Ebihara, Ken; Ogawa, Yoshihiro; Yasue, Shintaro; Yukioka, Hideo; Chusho, Hideki; Miyanaga, Fumiko; Miyazawa, Takashi; Fujimoto, Muneya; Kusakabe, Toru; Kobayashi, Nozomi; Hayashi, Tatsuya; Hosoda, Kiminori; Nakao, Kazuwa.

In: Metabolism: Clinical and Experimental, Vol. 54, No. 11, 01.11.2005, p. 1490-1498.

Research output: Contribution to journalArticle

Tanaka, T, Masuzaki, H, Ebihara, K, Ogawa, Y, Yasue, S, Yukioka, H, Chusho, H, Miyanaga, F, Miyazawa, T, Fujimoto, M, Kusakabe, T, Kobayashi, N, Hayashi, T, Hosoda, K & Nakao, K 2005, 'Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice', Metabolism: Clinical and Experimental, vol. 54, no. 11, pp. 1490-1498. https://doi.org/10.1016/j.metabol.2005.05.015
Tanaka, Tomohiro ; Masuzaki, Hiroaki ; Ebihara, Ken ; Ogawa, Yoshihiro ; Yasue, Shintaro ; Yukioka, Hideo ; Chusho, Hideki ; Miyanaga, Fumiko ; Miyazawa, Takashi ; Fujimoto, Muneya ; Kusakabe, Toru ; Kobayashi, Nozomi ; Hayashi, Tatsuya ; Hosoda, Kiminori ; Nakao, Kazuwa. / Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. In: Metabolism: Clinical and Experimental. 2005 ; Vol. 54, No. 11. pp. 1490-1498.
@article{faf94c14aaa74fb590ba1a6f8577cfa1,
title = "Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice",
abstract = "Steatosis is one of the most common liver diseases and is associated with the metabolic syndrome. A line of evidence suggests that peroxisome proliferator-activated receptor (PPAR) α and PPARγ are involved in its pathogenesis. Hepatic overexpression of PPARγ1 in mice provokes steatosis, whereas liver-specific PPARγ disruption ameliorates steatosis in ob/ob mice, suggesting that hepatic PPARγ functions as an aggravator of steatosis. In contrast, PPARα-null mice are susceptible to steatosis because of reduced hepatic fatty acid oxidation. PPARγ with mutations in its C-terminal ligand-binding domain (L468A/E471A mutant PPARγ1) have been reported as a constitutive repressor of both PPARα and PPARγ activities in vitro. To elucidate the effect of cosuppression of PPARα and PPARγ on steatosis, we generated mutant PPARγ transgenic mice (Liver mt PPARγ Tg) under the control of liver-specific human serum amyloid P component promoter. In the liver of transgenic mice, PPARα and PPARγ agonist-induced augmentation of the expression of downstream target genes of PPARα and PPARγ, respectively, was significantly attenuated, suggesting PPARα and PPARγ cosuppression in vivo. Suppression of PPARα and PPARγ target genes was also observed in the fasted and high-fat-fed conditions. Liver mt PPARγ Tg were susceptible to fasting-induced steatosis while being protected against high-fat diet-induced steatosis. The opposite hepatic outcomes in Liver mt PPARγ Tg as a result of fasting and high-fat feeding may indicate distinct roles of PPARα and PPARγ in 2 different types of nutritionally provoked steatosis.",
author = "Tomohiro Tanaka and Hiroaki Masuzaki and Ken Ebihara and Yoshihiro Ogawa and Shintaro Yasue and Hideo Yukioka and Hideki Chusho and Fumiko Miyanaga and Takashi Miyazawa and Muneya Fujimoto and Toru Kusakabe and Nozomi Kobayashi and Tatsuya Hayashi and Kiminori Hosoda and Kazuwa Nakao",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.metabol.2005.05.015",
language = "English",
volume = "54",
pages = "1490--1498",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice

AU - Tanaka, Tomohiro

AU - Masuzaki, Hiroaki

AU - Ebihara, Ken

AU - Ogawa, Yoshihiro

AU - Yasue, Shintaro

AU - Yukioka, Hideo

AU - Chusho, Hideki

AU - Miyanaga, Fumiko

AU - Miyazawa, Takashi

AU - Fujimoto, Muneya

AU - Kusakabe, Toru

AU - Kobayashi, Nozomi

AU - Hayashi, Tatsuya

AU - Hosoda, Kiminori

AU - Nakao, Kazuwa

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Steatosis is one of the most common liver diseases and is associated with the metabolic syndrome. A line of evidence suggests that peroxisome proliferator-activated receptor (PPAR) α and PPARγ are involved in its pathogenesis. Hepatic overexpression of PPARγ1 in mice provokes steatosis, whereas liver-specific PPARγ disruption ameliorates steatosis in ob/ob mice, suggesting that hepatic PPARγ functions as an aggravator of steatosis. In contrast, PPARα-null mice are susceptible to steatosis because of reduced hepatic fatty acid oxidation. PPARγ with mutations in its C-terminal ligand-binding domain (L468A/E471A mutant PPARγ1) have been reported as a constitutive repressor of both PPARα and PPARγ activities in vitro. To elucidate the effect of cosuppression of PPARα and PPARγ on steatosis, we generated mutant PPARγ transgenic mice (Liver mt PPARγ Tg) under the control of liver-specific human serum amyloid P component promoter. In the liver of transgenic mice, PPARα and PPARγ agonist-induced augmentation of the expression of downstream target genes of PPARα and PPARγ, respectively, was significantly attenuated, suggesting PPARα and PPARγ cosuppression in vivo. Suppression of PPARα and PPARγ target genes was also observed in the fasted and high-fat-fed conditions. Liver mt PPARγ Tg were susceptible to fasting-induced steatosis while being protected against high-fat diet-induced steatosis. The opposite hepatic outcomes in Liver mt PPARγ Tg as a result of fasting and high-fat feeding may indicate distinct roles of PPARα and PPARγ in 2 different types of nutritionally provoked steatosis.

AB - Steatosis is one of the most common liver diseases and is associated with the metabolic syndrome. A line of evidence suggests that peroxisome proliferator-activated receptor (PPAR) α and PPARγ are involved in its pathogenesis. Hepatic overexpression of PPARγ1 in mice provokes steatosis, whereas liver-specific PPARγ disruption ameliorates steatosis in ob/ob mice, suggesting that hepatic PPARγ functions as an aggravator of steatosis. In contrast, PPARα-null mice are susceptible to steatosis because of reduced hepatic fatty acid oxidation. PPARγ with mutations in its C-terminal ligand-binding domain (L468A/E471A mutant PPARγ1) have been reported as a constitutive repressor of both PPARα and PPARγ activities in vitro. To elucidate the effect of cosuppression of PPARα and PPARγ on steatosis, we generated mutant PPARγ transgenic mice (Liver mt PPARγ Tg) under the control of liver-specific human serum amyloid P component promoter. In the liver of transgenic mice, PPARα and PPARγ agonist-induced augmentation of the expression of downstream target genes of PPARα and PPARγ, respectively, was significantly attenuated, suggesting PPARα and PPARγ cosuppression in vivo. Suppression of PPARα and PPARγ target genes was also observed in the fasted and high-fat-fed conditions. Liver mt PPARγ Tg were susceptible to fasting-induced steatosis while being protected against high-fat diet-induced steatosis. The opposite hepatic outcomes in Liver mt PPARγ Tg as a result of fasting and high-fat feeding may indicate distinct roles of PPARα and PPARγ in 2 different types of nutritionally provoked steatosis.

UR - http://www.scopus.com/inward/record.url?scp=27344454809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27344454809&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2005.05.015

DO - 10.1016/j.metabol.2005.05.015

M3 - Article

C2 - 16253638

AN - SCOPUS:27344454809

VL - 54

SP - 1490

EP - 1498

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 11

ER -